NOVAMINE 15% Drug Patent Profile
✉ Email this page to a colleague
When do Novamine 15% patents expire, and when can generic versions of Novamine 15% launch?
Novamine 15% is a drug marketed by Hospira Inc and Baxter Hlthcare and is included in two NDAs.
The generic ingredient in NOVAMINE 15% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Novamine 15%
A generic version of NOVAMINE 15% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for NOVAMINE 15%
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NOVAMINE 15% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NOVAMINE 15%
US Patents and Regulatory Information for NOVAMINE 15%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | NOVAMINE 15% | amino acids | INJECTABLE;INJECTION | 017957-004 | Nov 28, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER | amino acids | INJECTABLE;INJECTION | 020107-001 | Feb 5, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
